<DOC>
	<DOCNO>NCT02606773</DOCNO>
	<brief_summary>The aim study evaluate bioavailability `` Novo C Plus '' vitamin C contain dietary supplement compare license vitamin C medication . The novelty product liposomal formulation .</brief_summary>
	<brief_title>`` Novo C Plus '' Vitamin C Containing Dietary Supplement Bioavailability Healthy Subjects</brief_title>
	<detailed_description />
	<mesh_term>Ascorbic Acid Deficiency</mesh_term>
	<mesh_term>Scurvy</mesh_term>
	<mesh_term>Vitamins</mesh_term>
	<mesh_term>Ascorbic Acid</mesh_term>
	<criteria>2165 year old healthy volunteer body weight &gt; 45 kg body height &gt; 150 cm plasma ascorbic acid screen &lt; 75 Âµmol/l sign write informed consent subject agree avoid vitamin C contain medication dietary supplement screen V0 visit ( maximum 15 day ) subject agree avoid high activity physical exercise 72 hour prior V0 visit confirm suspected active infection liver renal failure ( equal great CKD3 ) chronic disease affect absorption vitamin C metabolism severe metabolic disorder body mass index &gt; 35 kg/m2 malabsorption syndrome affect vitamin C metabolism heart failure , angina pectoris , ventricular arrhythmias atrial fibrillation &gt; 100/min ventricular rate gastrointestinal bleeding past three month uncontrolled diabetes mellitus ( HbA1c &gt; 8,5 % ) malignant disease alcohol drug abuse active psychiatric disorder , intention suicidal , disorder unconsciousness psychopathic disorder , lack cooperation know coagulopathy chronic obstructive lung disease active smoking ( 2 cigarette past 6 month ) untreated hypertension blood pressure great 165/95 mmHg gravidity breastfeed take 100 mg vitamin C daily within 2 week screen</criteria>
	<gender>All</gender>
	<minimum_age>21 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>November 2015</verification_date>
	<keyword>vitamin C supplementation</keyword>
</DOC>